pH-Responsive Alginate-Chitosan Microparticles Incorporating Tenebrio molitor-Derived Chitosan for Gastrointestinal Delivery of Antimicrobial Peptides

Background/Objectives: Probiotic-derived peptides are promising multifunctional metabolites with significant potential for disease prevention and treatment. However, their effectiveness is hindered by their susceptibility to gastrointestinal degradation. This study aimed to develop sustainable alginate–chitosan microparticles for oral peptide delivery, using chitosan extracted from Tenebrio molitor residues. Methods: Peptides isolated from Lactococcus lactis subsp. lactis ATCC 11454 and Bacillus subtilis subsp. subtilis NCIB 3610 were loaded into the microparticles via the external ionic gelation method. The microparticles were characterized for morphology, size, encapsulation efficiency, Fourier-Transform Infrared (FT-IR) profile, swelling, and pH-dependent release under simulated gastrointestinal conditions. Results: Microparticles had a particle size of approximately 511–576 μm, and encapsulation efficiencies of 74.8–83.3%, comparable to commercial chitosan formulations. FT-IR analysis supported efficient peptide incorporation into the polymer matrix. The formulations exhibited pH-dependent swelling and release, with minimal release at gastric pH 1.2 and substantially greater release at intestinal pH (6.8 and 7.4). Following INFOGEST simulated gastrointestinal digestion, encapsulated peptides retained antimicrobial activity against Enterococcus faecalis and Escherichia coli, while free peptides showed significantly reduced activity (p < 0.05). Empty microparticles maintained Caco-2 cell viability above 90% across the tested concentration range, indicating cytocompatibility, whereas peptide-loaded formulations exhibited dose-dependent cytotoxicity. Conclusions: Collectively, these findings demonstrate the potential of alginate–chitosan microparticles containing T. molitor-derived chitosan as a sustainable, pH-responsive platform for protecting antimicrobial peptides during gastrointestinal transit and facilitating intestinal delivery.

Authors

Institutions

Publication Details

Journal
Pharmaceutics
Published
2026-11-19
DOI
https://doi.org/10.3390/pharmaceutics18111493
Primary Topic
Advanced Drug Delivery Systems
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

pH-Responsive Alginate-Chitosan Microparticles Incorporating Tenebrio molitor-Derived Chitosan for Gastrointestinal Delivery of Antimicrobial Peptides

Ioannis Mourtzinos, Maria Touraki, Veronica S. Giourieva, Antigoni G. Margellou et al.
Pharmaceutics
Advanced Drug Delivery Systems
article

pH-Responsive Alginate-Chitosan Microparticles Incorporating Tenebrio molitor-Derived Chitosan for Gastrointestinal Delivery of Antimicrobial Peptides

Ioannis Mourtzinos, Maria Touraki, Veronica S. Giourieva, Antigoni G. Margellou, Christina Thoda, Anastasia Loukri, Paraskevi Evangelia Panou, Stavroula Mystridou, Konstantina Karagiota, Theodora Papadopoulou, Danai Agapi Kotopoulou
article en

Abstract

Background/Objectives: Probiotic-derived peptides are promising multifunctional metabolites with significant potential for disease prevention and treatment. However, their effectiveness is hindered by their susceptibility to gastrointestinal degradation. This study aimed to develop sustainable alginate–chitosan microparticles for oral peptide delivery, using chitosan extracted from Tenebrio molitor residues. Methods: Peptides isolated from Lactococcus lactis subsp. lactis ATCC 11454 and Bacillus subtilis subsp. subtilis NCIB 3610 were loaded into the microparticles via the external ionic gelation method. The microparticles were characterized for morphology, size, encapsulation efficiency, Fourier-Transform Infrared (FT-IR) profile, swelling, and pH-dependent release under simulated gastrointestinal conditions. Results: Microparticles had a particle size of approximately 511–576 μm, and encapsulation efficiencies of 74.8–83.3%, comparable to commercial chitosan formulations. FT-IR analysis supported efficient peptide incorporation into the polymer matrix. The formulations exhibited pH-dependent swelling and release, with minimal release at gastric pH 1.2 and substantially greater release at intestinal pH (6.8 and 7.4). Following INFOGEST simulated gastrointestinal digestion, encapsulated peptides retained antimicrobial activity against Enterococcus faecalis and Escherichia coli, while free peptides showed significantly reduced activity (p < 0.05). Empty microparticles maintained Caco-2 cell viability above 90% across the tested concentration range, indicating cytocompatibility, whereas peptide-loaded formulations exhibited dose-dependent cytotoxicity. Conclusions: Collectively, these findings demonstrate the potential of alginate–chitosan microparticles containing T. molitor-derived chitosan as a sustainable, pH-responsive platform for protecting antimicrobial peptides during gastrointestinal transit and facilitating intestinal delivery.

PharmaceuticsVol. 18(11)
Aristotle University of Thessaloniki (GR)
Advanced Drug Delivery Systems
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon